The PCE deficiency percentage washigh with high alanine amino transferase, aspartate amino transferase, ure and creatinin levels (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: It is aimed to reveal the frequency of pseudocholinesterase (PCE) deficiency, which is highly important for thepossible complications observed during the general anaesthesia applications.Method: The records of patients (age, sex, serum PCE effect levels, liver and kidney functions) were computerized and studiedon the data.Results: PCE level in 5.5% of the patients (n=15.309) were under the normal values.
📊
Key Findings & Data:Objective: It is aimed to reveal the frequency of pseudocholinesterase (PCE) deficiency, which is highly important for thepossible complications observed during the general anaesthesia applications.Method: The records of patients (age, sex, serum PCE effect levels, liver and kidney functions) were computerized and studiedon the data.Results: PCE level in 5.5% of the patients (n=15.309) were under the normal values.
💡
Conclusion & Impact:The PCE deficiency percentage washigh with high alanine amino transferase, aspartate amino transferase, ure and creatinin levels (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: It is aimed to reveal the frequency of pseudocholinesterase (PCE) deficiency, which is highly important for thepossible complications observed during the general anaesthesia applications.Method: The records of patients (age, sex, serum PCE effect levels, liver and kidney functions) were computerized and studiedon the data.Results: PCE level in 5.5% of the patients (n=15.309) were under the normal values. The PCE deficiency percentage washigh with high alanine amino transferase, aspartate amino transferase, ure and creatinin levels (p
Özet
Amaç: Genel anestezi uygulamalar›nda gözlenen olas› komplikasyonlar aç›s›ndan oldukça önemli olan psödokolinesteraz (PKE) eksikli¤i s›kl›¤›n› ortaya koymak amaçlanm›flt›r. Yöntem: Hastalar›n kay›tlar› (yafl, cinsiyet, serum PKE etki düzeyleri, karaci¤er ve böbrek fonksiyonlar›) bilgisayar ortam›nda yap›ld› ve veriler üzerinde çal›fl›ld›. Bulgular: Hastalar›n %5.5'inde (n = 15.309) PKE düzeyi normal de¤erlerin alt›ndayd›. PKE eksikli¤i yüzdesi, yüksek alanin amino transferaz, aspartat amino transferaz, üre ve kreatinin düzeyleri olan hastalarda yüksek bulundu (p
🔖
Cite This Article
SEVER, F., TOKAT, S., AKIN, M., KURT, D. T., KESKİN, G., SAYDAM, S., ÖZMERT, S., KIZILGÜN, M., TOKAT, A. O. (2022). THE INCIDENCE OF PSEUDOCHOLINESTERASE DEFICIENCY AND CONTRIBUTING FACTORS IN PEDIATRIC PATIENTS IN TURKEY. Anestezi Dergisi, Cilt: 26 - Sayı: 3, 159–163. https://ajindex.com/articles/440501
Kalow W. Heritable factors recognized in man by the use of drugs. In: Kalow W (ed). Pharmacogenetics: Heredity and the Response to Drugs. Philadelphia: WB Saunders Co, 1962: 69-136.
Davis L, Britten JJ, Morgan N. Cholinesterase: its significance in anesthetic practice. Anesthesia 1997; 52: 244-260.
Ama T, Bounmythavong S, Blaze J, Weismann M, Marienau MS, Nicholson WT. Implications of pharmacogenomics for anesthesia providers. AANA J 2010; 78: 393-399.
Kaufman L, Lehmann H, Silk E. Suxamethonium apnea in an infant. Expression of familial pseudocholinesterase deficiency in three generations. Br Med J 1960; 16: 166-167. Templeton AR. The theory of speciation via the founder principle. Genetics 1980; 94: 1011-1038.
Manoharan I, Wieseler S, Layer PG, Layer PG, Lockridge O, Boopathy R. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenet Genomics 2006; 16: 461-468.
Scott EM, Wright RC. A third type of serum cholinesterase deficiency in Eskimos. Am J Hum Genet 1976; 28: 253-256. Sayek ‹, Karahasano¤lu AM, Özand P. Pseudocholinesterase. 3. The presence of pseudocholinesterase variants in a Turkish population. Turk J Pediatr 1967; 9: 8-12.
Kutty KM, Payne RH. Serum pseudocholinesterase and very- low-density lipoprotein metabolism. J Clin Lab Anal 1994; 8: 247-250.
Kaya G, Akef A, Atalay A. [Pseudocholinesterase activity and genetic variants at 202 volunteers in Sivas]. Cumhuriyet Med J 2000; 22: 93-97. Y›ld›r›m S, fiahin AF, Döngel ‹, Erflan ‹, Özkan F. Sivas ilinde psödokolinesteraz eksikli¤i görülme s›kl›¤› ve iliflkili klinik parametreler. Türkiye Klinikleri J Anest 2012; 10: 84-88. Oropollo AT. Abnormal pseudocholinesterase levels in surgical population. Anesthesiology 1978; 48: 284-286.
Smith CL, Hunter JM, Jones RS. Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction. Anaesthesia 1987; 42: 522-555.
Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s Clinical Anesthesiology. Postanesthesia Care CH: 56. The McGraw-Hill Companies 2013: 1257-1276.
Ghazal E, Amin A, Wu A, Felema B, Applegate II RL. Impact of rocuronium vs succinylcholine neuromuscular blocking drug choice for laparoscopic pyloromyotomy: is there a difference in time to transport to recovery? Pediatric Anesthesia 2013; 23: 316-321.
Turkkal D. C, Gokmen N, Y›ldiz A et al. A cross-over, post- electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. J